Form 4: AtriCure Chief Legal Officer Acquires Shares Through Employee Stock Purchase Plan
Insider Transaction Report
AtriCure, Inc.'s Chief Legal Officer, Karl S. Dahlquist, acquired 822 shares of common stock through the company's Employee Stock Purchase Plan at a discounted price of $25.84 per share.
Summary
- Karl S. Dahlquist, Chief Legal Officer of AtriCure, Inc., acquired 822 shares of common stock.
- The acquisition occurred on June 30, 2025, pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan (ESPP) for the period ended on that date.
- The shares were purchased at a price of $25.84 per share.
- This purchase price represents 85% of the closing price of AtriCure's common stock on January 2, 2025, which was $30.40, marking the first trading day of the applicable offering period.
- Following this transaction, Karl S. Dahlquist beneficially owns a total of 68,551 shares of AtriCure, Inc. common stock.
Sentiment
Score: 7
Explanation: The acquisition of shares by an executive, even through a routine ESPP, generally indicates a positive sentiment towards the company's stock, as it increases their personal stake and aligns their interests with shareholders. It is a vote of confidence, albeit a standard one.
Positives
- An executive acquiring shares through an ESPP can signal confidence in the company's future prospects and alignment of interests with shareholders.
- The shares were purchased at a discounted price of $25.84 per share, reflecting the benefits provided by the Employee Stock Purchase Plan.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders may view the insider purchase as a positive signal of management confidence in the company's future performance and valuation.
Key Dates
| Date | Description |
|---|---|
| 2025-01-02 | First trading day of the applicable ESPP offering period, with a closing price of $30.40. |
| 2025-06-30 | Date of transaction where 822 shares were acquired through the ESPP for the period ended. |
| 2025-07-02 | Date the Form 4 was filed with the SEC. |
Recommendation
holdKeywords
AtriCure, ATRC, Karl S. Dahlquist, Chief Legal Officer, SEC Form 4, Insider Transaction, Stock Purchase, Employee Stock Purchase Plan, ESPP, Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.